These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4750415)

  • 1. Vital roles for the pharmacist.
    Kennedy EM
    J Am Pharm Assoc; 1973 Oct; 13(10):562-3. PubMed ID: 4750415
    [No Abstract]   [Full Text] [Related]  

  • 2. ADVERSE DRUG REACTIONS: FACTORS AND ROLE OF PHARMACIST IN THEIR PREVENTION.
    Bushra R; Baloch SA; Jabeen A; Bano N; Aslam N
    J Ayub Med Coll Abbottabad; 2015; 27(3):702-6. PubMed ID: 26721044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized methods of causality assessment for suspected adverse drug reactions.
    Hutchinson TA; Lane DA
    J Chronic Dis; 1986; 39(11):857-60. PubMed ID: 3539961
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacists contribute to the safety of medicines].
    Nishihara S
    Yakugaku Zasshi; 2011; 131(6):865-9. PubMed ID: 21628969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Student pharmacists: don't forget the product labeling.
    Minor PD; Cook GE
    J Am Pharm Assoc (2003); 2008; 48(6):696, 700. PubMed ID: 19019796
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effect reporting: pharmaceutical companies can't be trusted.
    Prescrire Int; 2015 Nov; 24(165):256. PubMed ID: 26688890
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the Effects of Pharmacist Intervention for Adverse Drug Reaction Detection and Exacerbation Avoidance].
    Imaura M; Yamaya T; Uehara N; Mano N; Nagase S; Kimura K; Kanno H; Yamada Y
    Yakugaku Zasshi; 2017; 137(6):767-774. PubMed ID: 28566582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions.
    Lawson DH
    Hum Toxicol; 1985 Mar; 4(2):122-6. PubMed ID: 4007876
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effects.
    Powell JR
    Pharmacotherapy; 2004 Mar; 24(3):422-5. PubMed ID: 15040659
    [No Abstract]   [Full Text] [Related]  

  • 12. Risky business.
    Nat Med; 2009 Apr; 15(4):345. PubMed ID: 19349989
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme.
    Robertson J; Walkom E; Moynihan R; Bero L; Henry D
    Int J Pharm Pract; 2010 Apr; 18(2):88-92. PubMed ID: 20441117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug quality in South Africa: perceptions of key players involved in medicines distribution.
    Patel A; Norris P; Gauld R; Rades T
    Int J Health Care Qual Assur; 2009; 22(5):547-60. PubMed ID: 19725374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peer review as a quality assurance mechanism in three pharmacist-run medication-refill clinics.
    Cram DL; Stebbins M; Eom HS; Ratto N; Sugiyama D
    Am J Hosp Pharm; 1992 Nov; 49(11):2727-30. PubMed ID: 1471637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of first year student pharmacists' perceptions of the pharmaceutical industry.
    Jacob B; Peasah S
    Curr Pharm Teach Learn; 2018 May; 10(5):637-642. PubMed ID: 29986824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Medicines Agency assesses safety reporting at Roche.
    Marshall H
    Lancet Oncol; 2012 Aug; 13(8):e331. PubMed ID: 23024993
    [No Abstract]   [Full Text] [Related]  

  • 19. Paying the pharmacist a fee for detecting adverse drug reactions.
    Spaulding G; Hefner DL; Campbell RK
    J Am Pharm Assoc; 1976 Feb; 16(2):86-9. PubMed ID: 1249398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary Care Requirements for Pharmacists-Clinical Reasoning Education at Schools of Pharmaceutical Sciences].
    Ashizawa T
    Yakugaku Zasshi; 2016; 136(7):939-44. PubMed ID: 27374954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.